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ABSTRACT
The type II restriction endonuclease TseI recognizes
the DNA target sequence 50-G^CWGC-30 (where
W=A or T) and cleaves after the first G to produce
fragments with three-base 50-overhangs. We have
determined that it is a dimeric protein capable of
cleaving not only its target sequence but also one
containing A:A or T:T mismatches at the central
base pair in the target sequence. The cleavage of
targets containing these mismatches is as efficient
as cleavage of the correct target sequence contain-
ing a central A:T base pair. The cleavage mechanism
does not apparently use a base flipping mechanism
as found for some other type II restriction endo-
nuclease recognizing similarly degenerate target
sequences. The ability of TseI to cleave targets
with mismatches means that it can cleave the
unusual DNA hairpin structures containing A:A or
T:T mismatches formed by the repetitive DNA se-
quences associated with Huntington’s disease
(CAG repeats) and myotonic dystrophy type 1 (CTG
repeats).
INTRODUCTION
Type II restriction endonucleases have found many uses in
molecular biology because of their ability to cleave DNA
molecules with extraordinary precision at speciﬁc se-
quences of base pairs. Thousands of restriction enzymes
have been discovered, and many are available commer-
cially (1). The restriction enzyme TseI, isolated originally
from a thermophilic bacterium of the genus Thermus,
displays optimal activity at 65C. TseI recognizes the
symmetric but ambiguous ﬁve-base pair sequence
50-G^CWGC-30 in double-strand (ds) DNA (where
W=A or T) and cleaves after the ﬁrst G to produce
fragments with three-base 50-overhangs (1). ApeKI, a
similar enzyme of identical speciﬁcity from the archaeon
Aeropyrum, displays optimum activity at even higher tem-
peratures (2).
X-ray crystallography has revealed two distinct struc-
tural classes of restriction enzymes that recognize quasi-
symmetric DNA sequences of this kind. Restriction
enzymes MvaI (speciﬁcity: CC^WGG) and BcnI
(CC^SGG where S=G or C) bind to DNA and are
active as small monomeric proteins (3–5). The proteins
contain only one catalytic site and accomplish ds
cleavage by sequential nicking and hydrolysing ﬁrst one
DNA strand and then the other in separate binding events
of opposite orientation (6,7). Each monomer interacts
with all ﬁve base pairs of the recognition sequence. The
interactions leading to recognition of the four deﬁned base
pairs are straightforward (3,4), but those leading to recog-
nition of the central ambiguous base pair are less well
understood, and thought perhaps to involve reversals in
hydrogen-bond conﬁgurations (6).
Restriction enzymes PspGI (^CCWGG) and Ecl18kI
(^CCNGG where N=any base), in contrast, bind to
DNA as homodimeric proteins (8,9). As each subunit
has a catalytic site, the homodimers have two and can
accomplish ds cleavage simultaneously, in a single
binding event, albeit that for Ecl18kI requires additional
interactions between neighbouring molecules at ﬂanking
sites (10). Each subunit of PspGI and Ecl18kI interact in a
conventional way with only half of the base pairs that
make up the recognition sequence, namely, the two
outer C:Gs that form each half-site. In both enzymes, re-
markably, the central bases are ﬂipped from the helix into
pockets, and the gap left behind is compressed, effectively
reducing the recognition sequences to just CCGG (8,9).
Recognition of the central base pair is thought to take
place mainly within the pockets; these accommodate any
base in Ecl18kI, but in some way discriminate against G
or C in PspGI (11). When 2-aminopurine (2-AP) is
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substituted for adenine at the central position in the rec-
ognition sequence, binding by PspGI and Ecl18kI
produces a marked increase in ﬂuorescence because of
base unstacking, a signature of base ﬂipping (12,13).
PspGI and Ecl18kI are similar to each other in both
structure and amino acid (aa) sequence. They are
distinct from BcnI and MvaI, which themselves are also
similar in sequence and structure. The structure of TseI
has not been solved, but its aa sequence, and that of the
closely similar ApeKI, shows little similarity to those of
the other four enzymes, suggesting that TseI might belong
to a third structural class, distinct from either of the other
two. It is unclear, then, whether TseI binds to its target
sequence as a monomer or a homodimer, and whether the
central base pair remains intra-helical during recognition
or becomes ﬂipped.
Given its recognition sequence, TseI will cleave CAG
and CTG trinucleotide repeats, which are involved in the
aetiology of a number of neurodegenerative diseases, such
as Huntington’s disease (HD; CAG repeats) and myotonic
dystrophy type 1 [CTG repeats; reviewed in (14,15)].
There is evidence that triplet repeats produce unusual
DNA structures, such as triplexes, hairpins, slipped-strand
DNA and G-quadruplexes (16). These structures affect the
mobility of DNA in agarose gels (e.g. 17), and they have
also been directly observed by electron microscopy
(18,19). Recently, we used atomic force microscopy
(AFM) to analyse DNA samples of various CAG repeat
lengths (20). We found that the structural proﬁle of the
DNA changed signiﬁcantly as repeat length increased.
DNA from wild-type mice appeared as short linear mol-
ecules, whereas when the CAG repeat length increased,
various DNA structures, including convolutions, folds
and protrusions, became apparent. Over 50% of DNA
molecules containing 408 CAG repeats contained one of
these unusual structures. We showed that the convoluted
DNA was sensitive to mung bean nuclease, indicating that
it contained hairpin mismatches. We then used TseI, to
further characterize the structures observed in the
super-long CAG repeats. We found that at room tempera-
ture, TseI preferentially cleaved linear regions of
858-repeat DNA, leaving behind the contorted regions.
In contrast, at 80C, TseI completely digested the DNA.
These observations suggested that TseI preferentially
cleaves CAG repeats within normal B-form DNA, but
that at higher temperatures, it can also cleave DNA con-
taining central A:A or T:T mismatches; mismatches that
will be present in the hairpins. We speculated that like
PspGI, TseI might also ﬂip out the central bases, and in
doing so, it might cleave such mismatched sequences by
accommodating adenine in both pockets, in the case of
A:A mismatches, or thymine in both pockets, in the case
of T:T mismatches. In the current study, we set out to test
this idea.
MATERIALS AND METHODS
TseI enzyme
The amino acid and DNA sequences for TseI are available
in GenBank under accession numbers JN035228 and
AEN19713. We thank David Hough of New England
Biolabs for the kind gift of puriﬁed protein. The protein
(378 aa; 5000 U/ml) had a concentration of 10.8 mM in
terms of TseI monomers based on a molecular weight of
41 780Da and an extinction coefﬁcient at 280 nm of 37930
M1 cm1. ProtParam (21) at http://web.expasy.org/cgi-
bin/protparam/protparam was used to calculate these
values, assuming all cysteine residues were reduced and
the N-terminal methionine was unprocessed.
Preparation of 2-aminopurine labelled oligonucleotides
Apart from oligonucleotides containing 2-aminopurine
(2-AP), all oligonucleotides were obtained from ATDbio
(Southampton). Solid-phase synthesis of 2-AP–containing
oligonucleotides was performed using phosphoramidite
chemistry on a MerMade DNA/RNA oligonucleotide syn-
thesiser (BioAutomation, USA) in a 50-trityl (4,40-
dimethoxytrityl, DMT) group-on manner. Puriﬁcation of
the synthesised oligonucleotides was done using standard
two-stage DMT-on/DMT-off reverse phase high-
performance liquid chromatography (HPLC). The
DMT-on full-length products possessed a prolonged reten-
tion time during reverse phase HPLC puriﬁcation and were
easily separated from failed sequences. The reaction was
detritylated with 40% acetic acid/water, and a further
DMT-off reverse phase HPLC puriﬁcation step was
applied for higher purity. A NAP-10 column (GE
Healthcare) was used for desalting, and a Speedvac was
used to concentrate the synthesized products. All
synthesized oligonucleotides were examined by ESI-
FTICR mass spectrometry to conﬁrm an accurate molecu-
lar mass. All the synthesized products were quantiﬁed using
UV-Vis absorbance at 260 nm with the extinction coefﬁ-
cient determined using Integrated DNA biophysics online
software (http://biophysics.idtdna.com/UVSpectrum.html).
Size-exclusion chromatography analysis for investigating
molecular mass of TseI in solution at different protein
concentrations
An analytical HPLC gel ﬁltration column calibrated with
protein standards (apoferritin 443 kDa, b-amylase
200 kDa, alcohol dehydrogenase 150 kDa, bovine serum
albumin 66 kDa and carbonic anhydrase 29 kDa) was
used to determine the molecular weight of TseI in a
buffer composed of 20mM Tris–HCl, 20mM 2-
(N-morpholino)ethanesulfonic acid (MES), 10mM mag-
nesium chloride, 7mM b-mercaptoethanol, 200mM
sodium chloride and 0.1mM ethylenediaminetetraacetic
acid (EDTA), pH 6.5, at room temperature as previously
described (22). The low pH is required for stability of the
silica-based chromatography material. The TseI was
tested at concentrations from 4000 to 100 nM.
Measurement of DNA binding to TseI by ﬂuorescent
anisotropy
The anisotropy duplex labelled at the 50-end on one strand
with hexachlororﬂuorescein (HEX) was used, Table 1.
Fluorescence anisotropy measurements were performed
using an Edinburgh Instrument FS900 photon counting
spectroﬂuorometer using a T-format measurement and
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analysed as previously described (23). The excitation
wavelength was 535 nm, emission wavelength was
555 nm and bandwidths were 5 nm. Eight hundred micro-
litres of 10 nM of the anisotropy duplex was placed in a
10-mm path length quartz cuvette at 25C. Small amounts
of TseI were added to the duplex solution using a micro-
litre syringe to achieve enzyme concentrations from 5 to
320 nM and gently mixed by magnetic stirring. The buffer
was 50mM potassium acetate, 20mM Tris–acetate,
10mM calcium acetate and 1mM dithiothreitol, pH 7.9.
Steady-state measurements of 2-AP–substituted DNA and
DNA–TseI complexes
The 2-AP-labelled oligonucleotides were synthesized,
annealed to fully or partially complementary strands
(Table 1) and used for investigating the interaction of
TseI with DNA. All duplexes were buffered with 50mM
potassium acetate, 20mM Tris–acetate, 10mM calcium
acetate and 1mM dithiothreitol, pH 7.9. Two hundred
microlitres of samples of 250 nM duplex plus 1500 nM
TseI was incubated for 20 min at 25C. Steady-state ﬂuor-
escence spectra were measured using a FluoroMax
(Horiba Jobin Yvon) photon counting spectro-
ﬂuorometer. Spectra were recorded with a bandpass of
10 nm for both excitation (315 nm) and emission.
Fluorescence-based TseI activity assay
The substrate duplexes consisted of a 50-HEX–labelled
oligonucleotide annealed to a complementary strand
labelled at the 30-end with a black hole quencher 1
group, Table 1. The buffer was 50mM potassium
acetate, 20mM Tris–acetate, 10mM magnesium acetate
and 1mM dithiothreitol, pH 7.9. The duplexes are essen-
tially non-ﬂuorescent in the ds-state and highly ﬂuorescent
in the single-stranded state achieved by cleavage with TseI
at a temperature greater than the melting temperature of
Table 1. Oligonucleotides and duplexes used in this study
Duplex name Sequence
2-AP:T duplex 1 AGGAGTGAAGTCGC2GCCCGTGCTCAAG (50–30)
TCCTCACTTCAGCGTCGGGCACGAGTTC (30–50)
A:2-AP duplex 2 AGGAGTGAAGTCGCAGCCCGTGCTCAAG (50–30)
TCCTCACTTCAGCG2CGGGCACGAGTTC (30–50)
T:2-AP duplex 3 AGGAGTGAAGTCGCAGCCCGTGCTCAAG (50–30)
TCCTCACTTC2GCGTCGGGCACGAGTTC (30–50)
2-AP:A duplex 4 AGGAGTGAAGTCGC2GCCCGTGCTCAAG (50–30)
TCCTCACTTCAGCGACGGGCACGAGTTC (30–50)
2-AP:2-AP duplex5 AGGAGTGAAGTCGC2GCCCGTGCTCAAG (50–30)
TCCTCACTTCAGCG2CGGGCACGAGTTC (30–50)
Anisotropy duplex A:T HEX -AGGAGTGAAGTCGCAGCCCGTGCTCAAG (50–30)
TCCTCACTTCAGCGTCGGGCACGAGTTC (30–50)
Anisotropy duplex G:C HEX -AGGAGTGAAGTCGCGGCCCGTGCTCAAG (50–30)
TCCTCACTTCAGCGCCGGGCACGAGTTC (30–50)
Anisotropy duplex A:A HEX -AGGAGTGAAGTCGCAGCCCGTGCTCAAG (50–30)
TCCTCACTTCAGCGACGGGCACGAGTTC (30–50)
Anisotropy duplex T:T HEX -AGGAGTGAAGTCGCTGCCCGTGCTCAAG (50–30)
TCCTCACTTCAGCGTCGGGCACGAGTTC (30–50)
Fluorescence assay A:T duplex HEX -AGGAGTGAAGTCGCAGCCCGTGCTCAAG (50–30)
BHQ1-TCCTCACTTCAGCGTCGGGCACGAGTTC (30–50)
Fluorescence assay A:A mismatch duplex HEX -AGGAGTGAAGTCGCAGCCCGTGCTCAAG (50–30)
BHQ1-TCCTCACTTCAGCGACGGGCACGAGTTC (30–50)
Fluorescence assay T:T mismatch duplex HEX -AGGAGTGAAGTCGCTGCCCGTGCTCAAG (50–30)
BHQ1-TCCTCACTTCAGCGTCGGGCACGAGTTC (30–50)
Fluorescence assay product duplex HEX -AGGAGTGAAGTCG (50–30)
BHQ1-TCCTCACTTCAGCGTC (30–50)
A:T duplex AGGAGTGAAGTCGCAGCCCGTGCTCAAG (50–30)
TCCTCACTTCAGCGTCGGGCACGAGTTC (30–50)
A:A duplex AGGAGTGAAGTCGCAGCCCGTGCTCAAG (50–30)
TCCTCACTTCAGCGACGGGCACGAGTTC (30–50)
T:T duplex AGGAGTGAAGTCGCTGCCCGTGCTCAAG (50–30)
TCCTCACTTCAGCGTCGGGCACGAGTTC (30–50)
G:C duplex AGGAGTGAAGTCGCGGCCCGTGCTCAAG (50–30)
TCCTCACTTCAGCGCCGGGCACGAGTTC (30–50)
G:G duplex AGGAGTGAAGTCGCGGCCCGTGCTCAAG (50–30)
TCCTCACTTCAGCGGCGGGCACGAGTTC (30–50)
13mer product sequence AGGAGTGAAGTCG (50–30)
15mer product sequence Phos-CAGCCCGTGCTCAAG (50–30)
12mer product sequence GGGCACGAGTTC (30–50)
16mer product sequence TCCTCACTTCAGCGTC-Phos (30–50)
Recognition sites of TseI are in bold.
HEX, hexachloroﬂuorescein group; BHQ1, black hole quencher 1; Phos, phosphate group; 2-AP, 2-aminopurine
analogue base.
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the cleavage products. The increase of the signal can easily
be quantiﬁed and initial reaction rates determined. All
samples were analysed with an Edinburgh Instrument
spectroﬂuorometer with excitation at 530 nm, emission
at 555 nm and 5 nm bandwidths. Each DNA sample
(100 ml) was placed in a quartz microcuvette with 10-mm
path length, put in the ﬂuorometer and allowed to reach
the assay temperature of 60C, whereupon a stable ﬂuor-
escence background signal was achieved. The ﬂuorescence
intensity as a function of time was immediately recorded
after addition of TseI to a constant monomer concentra-
tion of 32.4 nM. Photon counts were converted to the
amount of 50-HEX–labelled oligonucleotide product
released using a calibration curve. The substrate concen-
tration versus initial cutting rate was plotted and ﬁtted
using the Michaelis–Menten equation {v=Vmax(S)/
[KM+(S)]} to determine the kinetic parameters KM,
Vmax and kcat. To determine the rate of melting of the
products, a small aliquot of the ﬂuorescence assay
product duplex (1.12 mM), Table 1, was diluted with
buffer at 60C in the microcuvette and the ﬂuorescence
signal recorded.
Mass spectrometry
For mass spectrometry analysis of oligonucleotides,
LC-MS was used, with detection performed in the
negative mode. Brieﬂy, an Ultimate 3000 HPLC system
was used (Dionex Corporation, Sunnyvale, CA, USA),
equipped with an Aeris Widepore C18 reverse phase ana-
lytical column 50 2.1mm (Phenomenex). Six-microlitre
samples containing 5 mM of DNA duplex or
TseI-treated duplex were injected onto the column.
For chromatography, mobile phase A and B were
prepared comprising 98:2 water:ammonia and 49:49:2
water:MeOH:ammonia, respectively. Samples were
injected onto the analytical column, washed with mobile
phase A for 10min, followed by a 20-min linear gradient
elution (200ml/min) into 100% mobile phase B. MS data
was acquired on a Bruker 12 Tesla SolariXQe Fourier
Transform Ion Cyclotron Resonance (FT-ICR) instru-
ment (Bruker Daltonics, Billerica, MA, USA) equipped
with an electrospray ionization (ESI) source. Desolvated
ions were transmitted to a 6-cm Inﬁnity cell Penning trap.
Trapped ions were excited (frequency chirp 48–500 kHz at
100 steps of 25 ms) and detected between m/z 600 and 2000
for 0.5 s to yield a broadband 512 Kword time-domain
data set. Fast Fourier Transforms and subsequent
analyses were performed using DataAnalysis (Bruker
Daltonics) software. Isotope distributions of speciﬁc
charge states were predicted from theoretical empirical
formulas. These were overlaid on the recorded
experimental data.
Polyacrylamide gel showing the cleavage of matched and
mismatched duplexes by TseI
Unlabelled duplexes, Table 1, were used in this experiment
at a concentration of 10 mM. In all, 2.5 ml of TseI stock
solution (10.8 mM) was added to give a ﬁnal TseI concen-
tration of 0.26mM. The buffer was 50mM potassium
acetate, 20mM Tris–acetate, 10mM magnesium acetate
and 1mM dithiothreitol, pH 7.9. All samples were
incubated at 65C for 6 h in the reaction buffer and
then 2.5 ml run on a 15% polyacrylamide gel in 1 Tris/
Borate/EDTA buffer at 150 V, stained with SYBR Gold
and viewed under UV light. Single strands corresponding
to the reactants and products, Table 1, were run as
markers. The DNA marker ladder was O’RangeRuler
ﬁve base pairs DNA Ladder (Thermo Scientiﬁc).
Denaturing HPLC analysis for TseI-matched and
-mismatched cutting
Unlabelled duplexes, Table 1, were used in this experiment
at a concentration of 10 mM. When cleavage was to be
tested, 2.5 ml of TseI stock solution (10.8 mM) was added
to 100 ml of the duplex solution to give a ﬁnal TseI con-
centration of 0.26mM. All samples were incubated at 65C
for 12 h. The buffer was 50mM potassium acetate,
20mM Tris–acetate, 10mM magnesium acetate and
1mM dithiothreitol, pH 7.9. Twenty-microlitre samples
were injected onto the HPLC column. The injection
solely of TseI in the absence of the duplex gave no
HPLC signal above the baseline. A Gilson HPLC
equipped with absorption detection at 254 nm was used
for analysis of DNA cleavage. The reverse phase column
(C18 Jones Chromatography) was thermostatted at 65C.
A linear acetonitrile gradient from 5 to 65% acetonitrile
was generated by mixing 0.1 M acetic acid, 5% acetonitrile
and 0.1 M acetic acid and 65% acetonitrile aqueous
solution. The pH of the two solvents was adjusted to 6.5
with triethylamine.
RESULTS
Characterization of TseI
A preparation of TseI was analysed in SDS–PAGE
(Figure 1a) and by size-exclusion chromatography
(Figure 1b and c). The SDS–PAGE gel showed a single
band after Coomassie blue staining at a molecular weight
of 42 kDa close to that expected from the amino acid
sequence. Further analysis with a calibrated analytical
size-exclusion chromatography column showed a single
elution peak at a constant elution time irrespective of
protein concentration in a range from 100 to 4000 nM.
The calibration indicated a molecular weight of
100±18kDa, suggesting that TseI is a homodimer in
the buffer used (Figure 1c).
Binding of TseI to HEX-labelled duplexes containing
the target sequence or A:A, T:T or G:C base pairs at the
middle of the sequence was examined using the increase in
ﬂuorescence anisotropy of the HEX label caused by the
slowing of molecular rotation when the mass of the duplex
is increased by protein binding (23), Figure 1d. Binding to
the target sequence or to the G:C duplex occurred follow-
ing a normal one-site ligand-binding equation until a
protein concentration of 120 nM was reached. Above
this concentration, an additional binding event became
visible. Binding to the A:A and T:T mismatched
duplexes was weaker than to the properly base paired
duplexes, but it again followed a one-site binding
equation until a protein concentration of 220 nM was
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reached. Above this concentration, an additional binding
event became visible as the anisotropy increased further.
These additional binding events can only be due to an
increase in the amount of a species with even greater mo-
lecular mass than the complex of one DNA duplex with
one enzyme molecule. We attribute this additional binding
event to non-speciﬁc binding of an extra copy of the
protein to the protein–DNA complex. In support of this,
we note that the ﬁnal values of the anisotropy were similar
to those previously observed for HEX-labelled DNA
binding to M.EcoKI, an enzyme of molecular weight
170 kDa (23). The dissociation constants obtained by
ﬁtting the one-site binding equation to data up to
120 nM protein concentration gave values of 176±7,
149±6, 279±9 and 347±30nM for the duplexes con-
taining A:T, G:C, A:A and T:T base pairs, respectively, at
the central position of the target. Thus, TseI binds less
well to the distorted duplexes containing the mismatched
base pair. It is of interest that the binding of TseI to the
G:C duplex is almost identical to its binding to the A:T
duplex, even though the former sequence lacks the recog-
nition sequence for the enzyme. Thus, these data also
suggest that TseI must acquire its sequence speciﬁcity
after the binding event but before or concomitant with
the cleavage event.
Several restriction enzymes recognizing DNA target se-
quences similar to that recognized by TseI have been
shown by crystallography and 2-AP ﬂuorescence studies
to ﬂip out the central base pair in the target sequence and
to collapse the DNA duplex, thus converting a ﬁve-base
pair recognition sequence into a four-base pair recognition
sequence. The intensity increases in 2-AP emission because
of enzyme binding, and base ﬂipping ranged from 10- to
1000-fold for these enzymes. No structure is available for
TseI; therefore, the possibility that TseI uses base ﬂipping
was investigated by replacing the central bases with 2-AP
either paired with T (2-AP:T) or mismatched with A
(2-AP:A) or with another 2-AP (2-AP:2-AP). As a
control, 2-AP was also placed outside of the target
sequence and paired with T. The ﬂuorescence of the
duplexes containing 2-AP showed a typical 2AP
emission spectrum when excited at 315 nm with emission
maximum at 370 nm, Figure 1e. The addition of excess
TseI to ensure near complete binding of the duplex only
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Figure 1. Analysis of TseI enzyme. (a) 4–12% gradient SDS–PAGE gel
stained with Coomassie blue. Lane 1 shows the molecular mass markers
(kDa); lanes 2–4 show TseI samples at 5.4, 2.7 and 1.35 mM, respect-
ively. (b) Size-exclusion chromatography, as monitored by ﬂuorescence
emission at 350 nm with excitation at 295 nm, to investigate the solution
molecular mass. The elution proﬁle (1000 nM shown) showed a single
peak at 6.5min corresponding to a molecular mass of 100 kDa. (c)
Figure 1. Continued
Dependence of molecular mass as a function of protein concentration
injected onto the column. (d) Fluorescence anisotropy increase for
10 nM hexachloroFuorescein-labelled 28-bp DNA duplex as a
function of TseI monomer concentration. Duplex with the target
sequence (open squares, bold solid line), duplex with an A:A
mismatch (open circle, solid line), duplex with G:C at centre of the
target (solid squares, bold dashed line) and duplex with T:T
mismatch (solid circles, thin dashed line). Lines are determined using
a one-site binding equation for data up to a TseI concentration of
120 nM. (e) Steady-state ﬂuorescence emission spectra of 250 nM
2-aminopurine–substituted DNA in the absence/presence of 1.5 mM
TseI enzyme. The solid lines represent the ﬂuorescence intensity of
DNA in the absence of TseI for duplexes 2-AP:T duplex 1 (spectrum
1), A:2-AP duplex 2 (spectrum 3) and T:2-AP duplex 3 (spectrum 5).
The dotted lines represent the ﬂuorescence intensity of the same
duplexes in the presence of excess TseI (spectra 2, 4 and 6, respectively).
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caused a small increase (up to 50%) in the emission in-
tensity without changing the emission maximum wave-
length. This change in intensity was observed for all
locations and base pairings of the 2-AP probe. We
suspect that the modest intensity changes observed are
due to minor distortion of the DNA by the enzyme and
the placing of the 2-AP in a more hydrophilic environment
rather than base ﬂipping per se. However, it is also
possible that the presence of an aromatic aa, such as tryp-
tophan, in proximity to base-ﬂipped 2-AP could quench
the 2-AP ﬂuorescence and disguise base ﬂipping. In this
case, its ﬂuorescence would be similar in magnitude to that
observed for the duplex with 2-AP located outside the
recognition site. However, in the absence of further struc-
tural information, we take these results to suggest that
base ﬂipping does not occur when TseI binds to its
DNA target.
A continuous ﬂuorescence-based assay demonstrates that
TseI cleaves its target sequence even if it contains an A:A
or T:T mismatch
The endonuclease activity of TseI on short DNA duplexes
containing the target sequence and variations thereof was
investigated using a continuous ﬂuorescence assay. The
assay uses the difference in thermal stability of the 28 bp
substrate and the shorter products, which will be single
stranded at the assay temperature, to give a spectroscopic
signal, Figure 2a. This assay was initially proposed by
Waters et al. (23), who used the increase in absorption
because of the melting of the short products, and was
subsequently converted to ﬂuorescence measurements by,
for example, Li et al. (24), who used the melting of the
short products to remove a ﬂuorescence quencher from
contact with a ﬂuorescence HEX reporter. Provided that
the assay temperature lies between the melting tempera-
ture of the substrate and the products, the products melt
on cleavage by the enzyme, and the ﬂuorescence of the
ﬂuorophore is greatly enhanced. This assay works well
for TseI, Figure 2b, showing a substantial increase in
ﬂuorescence from a low-background level as a function
of time after addition of the enzyme. The ﬂuorescence
assay product duplex melts faster than the cleavage of
the substrate by the enzyme with melting complete after
60 s, Figure 2c. Thus the melting rate of the product does
not limit the assay.
The initial rate of ﬂuorescence increase was determined
as a function of substrate concentration for both a duplex
containing the target sequence and for one containing an
A:A or T:T mismatch in the middle of the sequence. All
three duplexes were cleaved by the enzyme, and in fact, the
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Figure 2. Fluorescence-based assay of TseI activity. (a) The 50-HEX–
labelled top strand was annealed with 30-Black Hole Quencher (BHQ)
1–labelled strand and became highly quenched. Adding TseI at elevated
temperature (60C) results in cleavage of the duplex, separation of the
ﬂuorophore–quencher pair and the appearance of ﬂuorescence. (b)
Fluorescence intensity as a function of time. Initially, a low signal
was observed. After 30 s, the sample chamber was opened, and an
Figure 2. Continued
aliquot of TseI was added to 100 nM duplex (ﬂuorescence assay A:T
duplex, Table 1). After closing the sample chamber at 50 s, TseI caused
a rapid increase in signal. (c) Time dependence of melting of the ﬂuor-
escence assay product duplex at 60C in the absence of any TseI. (d)
Michaelis–Menten plots of TseI cleavage for both matched (open
circles), A:A-mismatched DNA substrate (black circles) and
T:T-mismatched DNA substrate (open square). Error bars are
standard deviations for experiments performed in triplicate.
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mismatched duplexes were cleaved more quickly, as shown
in the Michaelis–Menten analysis, Figure 2d. The
maximum velocities for cleavage were 3.2±0.2,
6.0±0.8 and 5.4±0.3 nM s1 for the normal duplex,
for the A:A mismatched duplex and the T:T mismatched
duplex, respectively, giving kcat values of 0.20±0.01,
0.37±0.05 and 0.33±0.02 s1, respectively, assuming
100% of the enzyme molecules were active as dimers.
The Michaelis constants, KM, were 42.2±9.3,
80.7±30.6 and 95.2±14.8 nM for the normal duplex,
the A:A mismatched duplex and the T:T mismatched
duplex, respectively. The values of kcat/KM were, there-
fore, 4.0±0.95 103, 4.6±3.4 103 and
3.5±0.6 103 nM1 s1; hence, the enzyme has no pref-
erence for one substrate over the other, and the weaker
dissociation constant observed in the anisotropy assay for
the mismatched sequences is mirrored in the poorer KM
values.
Mass spectrometry conﬁrms that TseI cleaves mismatched
DNA duplexes at the same location as on normal DNA
FT-ICR mass spectrometry was used to identify the
nature of the cleaved DNA products. The uncleaved
duplexes after denaturation and separation by reverse
phase HPLC gave the expected molecular masses,
Table 2 and Supplementary Figures S1 and S2.
Treatment of the A:T, A:A and T:T duplexes with TseI
produced four shorter DNA strands as products. Each of
these products corresponded exactly to the mass expected
if cleavage occurred at the normal location for TseI,
Table 3 and Supplementary Figures S3 and S4.
TseI cleaves target sequences containing A:A and T:T
mismatches but not sequences containing G:C or G:G at
the central position of the target sequence
The ability of TseI to cleave target sequences containing a
mismatch was unexpected and would indicate a new use
for TseI in investigating A:A and T:T mismatches
generated by the formation of hairpins in repetitive
DNA sequences such (CAG)n found in many genetic
diseases. For this reason, the action of TseI on further
mismatched duplexes was explored.
Rather than perform full enzyme activity studies on
each possible mismatch using the ﬂuorescence assay, we
performed gel assays, Figure 3, and HPLC assays,
Supplementary Figure S5, for cleavage on duplexes con-
taining various base pairs or mismatches in the central
position of the target sequence. Figure 3 shows that
28-bp duplexes containing mismatches of A or T were
all cleaved into shorter duplexes as effectively as the
normal cognate sequence, but that those duplexes contain-
ing G or C at the central position were not cleaved as
expected, as they lacked the target sequence. Cleavage
was complete for the A:T , T:T and A:A duplexes as
would be predicted from the kinetic parameters
determined in the continuous ﬂuorescence assay.
HPLC analysis of duplex substrates and products using
reverse phase chromatography (run at high temperature to
denature the DNA) was performed, Supplementary
Figure S5. The substrate duplexes did not denature on T
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the column and eluted as a single peak for all substrates
investigated, namely, A:T, A:A, T:T, G:C and G:G. The
shorter product strands eluted as poorly resolved peaks at
an elution time substantially lower than that of the
uncleaved DNA strands; consequently, cleaved DNA
could be clearly distinguished from uncleaved DNA. The
28-base single strands eluted at the same time as the full-
length duplexes or slightly later. The absorption elution
proﬁles, Supplementary Figure S5, clearly demonstrated
that duplexes containing the normal target sequence or
A:A or T:T mismatches were cleaved. The cleavage
seemed to be incomplete for these three duplexes in
contrast to the assay shown in Figure 3, where the A:T,
A:A and T:T duplexes were completely cleaved. This may
be due to the enzyme remaining bound to a fraction of the
cleavage products and slowing their elution. Duplexes
lacking the target site or containing G:G or C:C
mismatches present at the central base pair of the target
sequence were not cleaved. Duplexes containing 2-AP
instead of A were also cleaved when paired with T or
mismatched with A or 2-AP (2-AP:T duplex 1, A:2-AP
duplex 2, 2-AP:A duplex 4 and 2-AP:2-AP duplex 5
from Table 1) (data not shown).
DISCUSSION
Data presented here show that TseI cleaves not only its
cognate sequence GCWGC but also sequences in which
the central base pair is an A:A or T:T mismatch. In the
apparent absence of base ﬂipping of the central base pair,
as observed for other restriction enzymes recognizing
similar sequences (8,9,11–13), the mode of recognition of
the central base pair must be rather unusual for discrim-
ination of a base pair containing A and T from one con-
taining G and C. Normally, discrimination of A:T/T:A
from G:C/C:G would use minor groove interactions and
not rely on DNA distortions, such as base ﬂipping.
However, an A:A or G:G mismatch will distort the
DNA helix at the centre of the TseI target sequence to
approximately similar degrees; therefore, it is difﬁcult to
rationalize how this enzyme can recognize the central base
pair in such a way as to disfavour G and C. Perhaps the
duplex undergoes a degree of bending at the central base
pair to provide the necessary discrimination. However,
solving this problem will require X-ray crystallography
and would reveal whether TseI and the related ApeKI
had a third type of fold distinct from the other restriction
enzymes recognizing similarly degenerate targets (3–13).
The cleavage properties of TseI allow it to digest not
only CAG repeat sequences in normal duplex DNA but
also the mismatched sequences caused by hairpin extru-
sion in long tracts of such repetitive DNA. In fact, we
observed this dual action of TseI recently using AFM
imaging of the degradation of the highly convoluted
DNA structures formed by annealing DNA strands con-
taining long CAG repeats (20). The motivation for this
previous study was to understand the change in DNA
structure as CAG repeat length increased, a change that
might be relevant to the aetiology of HD. In HD, the
presence of an expanded CAG repeat in the codingT
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region of HTT, the gene encoding Huntingtin, produces
an expanded polyglutamine sequence in the expressed
protein, thereby rendering it neurotoxic (14). The thresh-
old CAG repeat length that causes HD is 36, and there is
an approximate correlation between the length of the
CAG tract and the age of onset of the disease (25–27).
Confounding this relationship is instability of repeat
length, which occurs both in humans (28–32) and in
mouse models of HD (33–37). In fact, super-long CAG
expansions up to 1000 have been found in neurons from
the brains of patients with adult-onset HD (31,35).
Interestingly, it was shown recently that mice carrying
the ﬁrst exon of the human HD gene (R6/2 strain) with
a super-long (500) CAG repeat were found to have a
delayed onset of the disease phenotype and prolonged
survival compared with mice with shorter repeats
(38,39). There is a pronounced (>60%) reduction in
both mRNA levels and expression in mice with more
than 335 CAG repeats as compared with mice with
150 repeats (39), which might contribute to the observed
phenotypic amelioration. We speculated that super-long
DNA adopts unusual structures that progressively
reduce the efﬁciency of transcription of the HTT gene,
and we went on to observe the presence of these structures
by AFM imaging (20). Signiﬁcantly, TseI preferentially
cleaved normal duplex DNA and digested the mismatched
DNA only at higher temperatures (80C). In the present
work, although TseI showed no preference for digestion of
base paired over mismatched substrates at 60C, it did
cleave mismatched substrates faster; hence, the tempera-
ture dependence of TseI action is different on the two
substrates. By judicious choice of several incubation tem-
peratures, therefore, it should be possible to use the
enzyme to discriminate between the two forms of DNA.
For this reason, we suggest that TseI should be a useful
tool, complementary to the use of the EcoP15I restriction
enzyme (40), for exploring the role of DNA structure in
triplet repeat expansion diseases, such as HD and
myotonic dystrophy type 1.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online:
Supplementary Figures 1–5.
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Figure 3. Polyacrylamide gel analysis of matched and mismatched DNA duplexes being cut by TseI. Lane M was the molecular mass marker with
10, 15, 20 and 30 bp DNA indicated. DNA cleavage of A:T, T:T and A:A duplexes by TseI yields four 12–16mer single-strand oligonucleotides
matching those shown in the products lane.
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